Discovery, Replication, and Validation of Biomarkers of the DASH Diet and Hypertension

DASH 饮食和高血压生物标志物的发现、复制和验证

基本信息

  • 批准号:
    10678862
  • 负责人:
  • 金额:
    $ 70.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT Diet is a modifiable risk factor for one of the most serious threats to global public health: cardiovascular disease. The Dietary Approaches to Stop Hypertension (DASH) dietary pattern is one example of a high- quality diet that is high in fruits, vegetables, and low-fat dairy products and low in sodium, saturated fat, and cholesterol. The DASH diet is widely recognized as an effective approach for the prevention of hypertension, cardiovascular disease, and related cardiometabolic diseases. Existing biomarkers of dietary intake are few and represent single nutrients rather than a holistic dietary pattern. Metabolomics and proteomics are high- throughput methods for efficient measurement of compounds in biological specimens. The metabolome reflects the breakdown products of food that is consumed and can represent not only food items and their components but also dietary patterns. The proteome represents biological function and activity, which complements the metabolomic profile. We propose to conduct untargeted metabolomics and proteomics for the discovery of novel biomarkers of the DASH diet as well as biomarkers of DASH diet mediated blood pressure reduction. Findings will be replicated in two independent study populations and validated by using targeted, quantitative assays of candidate biomarkers. This cost-effective proposal leverages the existence of study data and biospecimens in the NHBLI BioLINCC repository as well as existing omics data. The study team is led by a K01-funded, early stage investigator who has been trained in metabolomics of diet and chronic disease outcomes. Study team members are established, senior investigators who have a history of collaboration with the Principal Investigator and complementary expertise in nutritional biochemistry, untargeted metabolomics and proteomics platforms, laboratory methodology, biostatistics, dietary intake, blood pressure, and deep knowledge of the study populations to be investigated. This proposed research will advance the current methods for assessing dietary intake and will provide insights for clinically-important, diet- modifiable metabolic pathways.
摘要 饮食是对全球公共健康最严重威胁之一的可改变风险因素:心血管疾病 疾病停止高血压的饮食方法(DASH)饮食模式是高血压的一个例子。 高质量的饮食,水果,蔬菜,低脂乳制品和低钠,饱和脂肪, 胆固醇DASH饮食被广泛认为是预防高血压的有效方法, 心血管疾病和相关的心脏代谢疾病。现有的饮食摄入生物标志物很少 代表单一营养素而不是整体饮食模式。代谢组学和蛋白质组学是高- 用于有效测量生物样品中的化合物的通量方法。代谢组 反映所消耗的食物的分解产物,不仅可以代表食物及其 还有饮食模式。蛋白质组代表生物学功能和活性, 补充了代谢组学特征我们建议进行非靶向代谢组学和蛋白质组学, DASH饮食的新生物标志物以及DASH饮食介导的血液的生物标志物的发现 减压研究结果将在两个独立的研究人群中重复,并通过使用 候选生物标志物的靶向定量测定。这一具有成本效益的提议利用了 NHBLI BioLINCC储存库中的研究数据和生物标本以及现有的组学数据。研究 团队由K 01资助的早期研究人员领导,他接受过饮食和慢性代谢组学的培训。 疾病结果。研究小组成员是已确定的,有以下病史的高级研究者: 与主要研究者的合作以及营养生物化学方面的互补专业知识, 非靶向代谢组学和蛋白质组学平台、实验室方法学、生物统计学、饮食摄入量、血液 压力,以及对研究人群的深入了解。这项研究将 推进目前评估饮食摄入量的方法,并将为临床重要的饮食提供见解, 改变代谢途径。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Plant-based diets, pescatarian diets and COVID-19 severity: a population-based case-control study in six countries.
基于植物的饮食,pescatarian饮食和共同饮食量表:六个国家的一项基于人群的病例对照研究。
  • DOI:
    10.1136/bmjnph-2021-000272
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kim H;Rebholz CM;Hegde S;LaFiura C;Raghavan M;Lloyd JF;Cheng S;Seidelmann SB
  • 通讯作者:
    Seidelmann SB
Access to personal protective equipment in exposed healthcare workers and COVID-19 illness, severity, symptoms and duration: a population-based case-control study in six countries.
  • DOI:
    10.1136/bmjgh-2020-004611
  • 发表时间:
    2021-01
  • 期刊:
  • 影响因子:
    8.1
  • 作者:
    Kim H;Hegde S;LaFiura C;Raghavan M;Sun N;Cheng S;Rebholz CM;Seidelmann SB
  • 通讯作者:
    Seidelmann SB
Plant-based diets and incident cardiovascular disease and all-cause mortality in African Americans: A cohort study.
  • DOI:
    10.1371/journal.pmed.1003863
  • 发表时间:
    2022-01
  • 期刊:
  • 影响因子:
    15.8
  • 作者:
    Weston LJ;Kim H;Talegawkar SA;Tucker KL;Correa A;Rebholz CM
  • 通讯作者:
    Rebholz CM
A Low-Sodium DASH Dietary Pattern Affects Serum Markers of Inflammation and Mineral Metabolism in Adults with Elevated Blood Pressure.
低钠 DASH 饮食模式会影响血压升高成人的炎症和矿物质代谢血清标志物。
  • DOI:
    10.1093/jn/nxab236
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sullivan,ValerieK;Appel,LawrenceJ;Seegmiller,JesseC;McClure,ScottT;Rebholz,CaseyM
  • 通讯作者:
    Rebholz,CaseyM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Casey Marie Rebholz其他文献

Casey Marie Rebholz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Casey Marie Rebholz', 18)}}的其他基金

Discovery, Replication, and Validation of Biomarkers of the DASH Diet and Hypertension
DASH 饮食和高血压生物标志物的发现、复制和验证
  • 批准号:
    10478910
  • 财政年份:
    2021
  • 资助金额:
    $ 70.42万
  • 项目类别:
Discovery, Replication, and Validation of Biomarkers of the DASH Diet and Hypertension
DASH 饮食和高血压生物标志物的发现、复制和验证
  • 批准号:
    10829021
  • 财政年份:
    2021
  • 资助金额:
    $ 70.42万
  • 项目类别:
Metabolomic Markers of Dietary Factors Associated with Kidney Health
与肾脏健康相关的饮食因素的代谢组学标志物
  • 批准号:
    10333394
  • 财政年份:
    2021
  • 资助金额:
    $ 70.42万
  • 项目类别:
Metabolomic Markers of Dietary Factors Associated with Kidney Health
与肾脏健康相关的饮食因素的代谢组学标志物
  • 批准号:
    10191255
  • 财政年份:
    2021
  • 资助金额:
    $ 70.42万
  • 项目类别:
Discovery, Replication, and Validation of Biomarkers of the DASH Diet and Hypertension
DASH 饮食和高血压生物标志物的发现、复制和验证
  • 批准号:
    10532973
  • 财政年份:
    2021
  • 资助金额:
    $ 70.42万
  • 项目类别:
Discovery, Replication, and Validation of Biomarkers of the DASH Diet and Hypertension
DASH 饮食和高血压生物标志物的发现、复制和验证
  • 批准号:
    10295307
  • 财政年份:
    2021
  • 资助金额:
    $ 70.42万
  • 项目类别:
Dietary Biomarkers and Cardioprotective Mechanisms of the DASH-Sodium Diet.
DASH-钠饮食的膳食生物标志物和心脏保护机制。
  • 批准号:
    9587549
  • 财政年份:
    2018
  • 资助金额:
    $ 70.42万
  • 项目类别:
Metabolomics for Identifying Biomarkers of Dietary Intake & Kidney Disease Progression
用于识别膳食摄入生物标志物的代谢组学
  • 批准号:
    9351513
  • 财政年份:
    2016
  • 资助金额:
    $ 70.42万
  • 项目类别:
Metabolomics for Identifying Biomarkers of Dietary Intake & Kidney Disease Progression
用于识别膳食摄入生物标志物的代谢组学
  • 批准号:
    9179786
  • 财政年份:
    2016
  • 资助金额:
    $ 70.42万
  • 项目类别:

相似海外基金

Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
  • 批准号:
    10568717
  • 财政年份:
    2023
  • 资助金额:
    $ 70.42万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10419967
  • 财政年份:
    2022
  • 资助金额:
    $ 70.42万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10592441
  • 财政年份:
    2022
  • 资助金额:
    $ 70.42万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10369750
  • 财政年份:
    2021
  • 资助金额:
    $ 70.42万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10633248
  • 财政年份:
    2021
  • 资助金额:
    $ 70.42万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10487516
  • 财政年份:
    2021
  • 资助金额:
    $ 70.42万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    10228564
  • 财政年份:
    2018
  • 资助金额:
    $ 70.42万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    9347041
  • 财政年份:
    2017
  • 资助金额:
    $ 70.42万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9480702
  • 财政年份:
    2016
  • 资助金额:
    $ 70.42万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9906853
  • 财政年份:
    2016
  • 资助金额:
    $ 70.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了